EX-23.1 8 tm249520d2_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement (No. 333-278197) on Form S-1 of Cyclacel Pharmaceuticals, Inc. and subsidiaries of our report dated March 21, 2024, relating to the consolidated financial statements of Cyclacel Pharmaceuticals, Inc. and subsidiaries, appearing in the Annual Form 10-K of Cyclacel Pharmaceuticals, Inc. for the year ended December 31, 2023.

 

We also consent to the reference to our firm under the heading “Experts” in such Prospectus.

 

/s/ RSM US LLP

 

New York, New York

April 19, 2024